Yati Pharmaceuticals Private Limited
About Yati Pharmaceuticals Private Limited
Data last updated:
Yati Pharmaceuticals Private Limited is a private limited company based in Muzaffarnagar, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2010PTC063660. Its GSTIN is 09AAACY5035C1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anil Bhatnagar (Whole-Time Director) and Akhilesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 161 – Iind Floor Shiva Complex Dwarika Puri, Muzaffarnagar, Uttar Pradesh, India – 251001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.39 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹11.87 Lakh (net margin 2.2%) and EBITDA of ₹19.7 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 22% over five years.
The company has about 35 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Yati Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100UR2010PTC033279. The current CIN is U24100UP2010PTC063660, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100UP2010PTC063660 | Current |
| U24100UR2010PTC033279 | Previous |
Contact details
Yati Pharmaceuticals Private Limited's registered office is in Muzaffarnagar, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address161 – Iind Floor Shiva Complex Dwarika Puri, Muzaffarnagar, Uttar Pradesh, India – 251001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Yati Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yati Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Yati Pharmaceuticals Private Limited, buy the company report.
Financials of Yati Pharmaceuticals Private Limited
FY 2025 filings availableYati Pharmaceuticals Private Limited reported revenue of ₹5.39 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 16% growth in the latest year. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yati Pharmaceuticals Private Limited, buy the company report.
Board of directors of Yati Pharmaceuticals Private Limited
Yati Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhilesh Kumar Singh | Director | 26 Dec 2011 | 14 Years 10 Months | Current |
| Bhupendra Singh | Director | 29 Oct 2011 | 15 Years 0 Months | Current |
| Anil Bhatnagar Also directs: Pankon Biotech Solutions Private Limited | Whole-Time Director | 29 Oct 2011 | 15 Years 0 Months | Current |
| Deependra Singh Malik | Director | 31 Aug 2010 | 16 Years 2 Months | Current |
Peer comparison
Yati Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abbey Healthcare Private Limited | ₹5.42 Cr (FY 2025) | -20.0% | Kolkata, West Bengal, India | |||
| Susruta Agencies (Mas) Private Limited | ₹5.41 Cr (FY 2023) | -27.0% | Kanchipuram, Tamil Nadu, India | |||
| Yati Pharmaceuticals Private Limitedthis company | ₹5.39 Cr (FY 2025) | ₹11.87 Lakh | 2.2% | 16.0% | 35 | Muzaffarnagar, Uttar Pradesh, India |
| NBMS Global Trade Private Limited | ₹5.39 Cr (FY 2025) | 34.0% | Delhi, India | |||
| Biosync Pharmaceuticals Private Limited | ₹5.38 Cr (FY 2025) | -1.0% | Chandigarh, India | |||
| Upsilon Pharmaceuticals Health Care Private Limited | ₹5.37 Cr (FY 2024) | 3.0% | Gwalior, Madhya Pradesh, India | |||
| Rafflesia Life Sciences Private Limited | ₹5.36 Cr (FY 2025) | 5.0% | Delhi, India |
To see the full peer comparison of Yati Pharmaceuticals Private Limited, buy the company report.
Auditor
Yati Pharmaceuticals Private Limited is audited by R S GARG & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S GARG & ASSOCIATES | FY 2021 | 011438C |
Shareholding
The shareholding of Yati Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Yati Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Feb 2020 | 100430728 | State Bank of India | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Yati Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yati Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Yati Pharmaceuticals Private Limited has a workforce of 35 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Yati Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACY5035C1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Yati Pharmaceuticals Private Limited, buy the company report.
Recent activity
Yati Pharmaceuticals Private Limited has 5 board changes on record since 2010: 4 appointments and 1 cessation. The latest: Ajay Kumar ceased to be Director on 25 Sep 2012.
Frequently asked questions
Yati Pharmaceuticals is an active private limited company based in Muzaffarnagar, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 August 2010 (16+ years old) and is registered under CIN U24100UP2010PTC063660.
Yati Pharmaceuticals has 4 current directors:
- Anil Bhatnagar - Whole-Time Director
- Akhilesh Kumar Singh - Director
- Bhupendra Singh - Director
- Deependra Singh Malik - Director
The latest financial statements of Yati Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Yati Pharmaceuticals is 09AAACY5035C1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Yati Pharmaceuticals is U24100UP2010PTC063660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yati Pharmaceuticals was incorporated on 31 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Yati Pharmaceuticals by revenue are Abbey Healthcare Private Limited, Susruta Agencies (Mas) Private Limited, NBMS Global Trade Private Limited, Biosync Pharmaceuticals Private Limited, Upsilon Pharmaceuticals Health Care Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajay Kumar ceased to be Director on 25 Sep 2012. Akhilesh Kumar Singh was appointed as Director on 26 Dec 2011. Anil Bhatnagar was appointed as Whole-Time Director on 29 Oct 2011. Yati Pharmaceuticals has 5 board changes on record in total.
The registered office of Yati Pharmaceuticals is at 161 – Iind Floor Shiva Complex Dwarika Puri, Muzaffarnagar, Uttar Pradesh, India – 251001.
Yati Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Yati Pharmaceuticals has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
